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AbstrAct
Introduction To estimate the prevalence of use 
of different sources of contraceptive supplies in 
Britain and its variation by key demographic and 
behavioural characteristics.
Methods Cross-sectional probability sample 
survey of women and men aged 16–74 years, 
resident in Britain, interviewed between 2010 
and 2012. Analyses reported here were of 
4571 women and 3142 men aged 16–44 years 
who reported having vaginal sex in the past 
year. Those relying exclusively on sterilisation 
(including hysterectomy) were excluded. Sources 
of contraceptive supplies were categorised as: 
general practice, community clinic, retail and 
other. Prevalence of use of these sources was 
estimated, and associated factors examined.
Results Some 87.0% of women and 73.8% of 
men accessed at least one source of contraceptive 
supplies in the previous year. Most women (59.1%) 
used general practice and most men (54.6%) 
used retail outlets. Community clinics were less 
commonly used, by 23.0% of women and 21.3% 
of men, but these users were younger and at 
greater sexual health risk. These associations were 
also observed among the 27.3% of women and 
30.6% of men who used more than one source 
category (general practice, community clinic or 
retail) for contraceptive supplies.
Conclusions People in Britain use a variety of 
sources to obtain contraceptive supplies and 
some sources are more commonly used by those 
more vulnerable to poorer sexual health. Our 
findings suggest that national policy changes to 
increase access to contraceptive methods have 
had an effect on the diversity of services used.
IntroductIon
Contraceptive supplies have been avail-
able free of charge to all wishing to 
prevent pregnancy from the National 
Health Service (NHS) in Britain since 
the early 1970s. Open-access contra-
ceptive services are provided in general 
practice, family planning clinics (FPCs) 
and young people’s services. The availa-
bility of a range of contraceptive sources 
and services including retail outlets helps 
ensure that the needs of different users are 
met.
The first decade of the 21st century 
saw several changes in the delivery of 
contraceptive services in Britain, largely in 
response to national strategies to improve 
sexual and reproductive health.1–4 Guid-
ance relating to long-acting reversible 
contraceptives (LARC) from the National 
Institute of Health and Care Excellence 
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Key message points
 ► General practice continues to be the 
most commonly used source by women 
for contraceptive supplies. It is therefore 
important that relevant practitioner 
skills and willingness to provide all 
methods be maintained in this setting. 
 ► Integrated sexual and reproductive 
health clinics and wider contraceptive 
provision in community settings, such 
as in schools and colleges, have helped 
reach those who have not accessed 
more traditional services in the past. 
 ► A strong case can be made for the 
provision of high-quality services in 
different settings and with different 
styles of service delivery to ensure 
that women and men have access to 
contraception that meets their needs.
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extended their availability to general practice.5 Recom-
mendations have been made for availability of contra-
ception in schools and other educational settings 
to improve access for young people,6 and the trend 
towards integration of FPCs and genitourinary medi-
cine (GUM) services has increased the likelihood that 
those attending for the treatment of sexually trans-
mitted infection (STI) leave the service with contra-
ception.7 8 During the same period, the provision 
of over-the-counter emergency contraception has 
increased.9 10
Of interest is the extent to which these changes may 
be reflected in patterns of contraceptive service use. In 
this article, we analyse data from the third National 
Survey of Sexual Attitudes and Lifestyles (Natsal-3) 
to estimate the prevalence of use of different sources 
of contraceptive supplies in Britain and its variation 
by key demographic and behavioural characteristics. 
In doing so, we update similar information from the 
second survey (Natsal-2).11
Methods
Data were analysed from Natsal-3, a multistage, 
clustered and stratified probability sample survey of 
15 162 British residents aged 16–74 years interviewed 
between September 2010 and August 2012. Partici-
pants were interviewed in their homes using a combi-
nation of face-to-face computer-assisted personal 
interview (CAPI) and computer-assisted self-interview 
(CASI) for more sensitive questions. The sampling 
frame was the Postcode Address File. The response 
rate was 57.7% and the cooperation rate, for all the 
eligible addresses contacted, was 65.8%. Full details of 
the methods used in Natsal-3 and the characteristics of 
the complete sample are reported elsewhere.12–14
Measures
Participants were asked in the CAPI which methods of 
contraception they or together with a partner had used 
in the past year. Those reporting use of any method(s) 
were asked to identify which sources of supply they 
had used from a card showing all available options with 
the following question: “Have you got contraception 
from any of these sources in the last year?”.15 Sources 
listed were grouped into four categories: general prac-
tice (doctor or nurse), community clinic (sexual health 
(GUM) clinic, family planning/contraceptive/reproduc-
tive health clinic, youth services or school/college/univer-
sity), retail (pharmacy/chemist, website, petrol station/
supermarket/other shop, vending machine or mail order) 
and other (emergency department at hospital, antenatal 
clinic, private doctor or other). Sociodemographic char-
acteristics used in this analysis included age, ethnic group, 
and educational attainment. Area of residence was cate-
gorised as rural or urban and area-related socioeconomic 
status was measured using the Index of Multiple Depri-
vation (IMD).16 IMD is a multi-dimensional measure 
of area (neighbourhood)-level deprivation based on the 
participants’ postcode. Sexual health and lifestyle indi-
cators included current relationship status, parity, STI 
diagnosis and pregnancy, including planning status (ie, 
ambivalent/unplanned, planned, trying or not pregnant).
statistical analyses
Women and men aged 16–44 years were included if 
they reported having (i) had vaginal intercourse in 
the past year, and (ii) not exclusively relied on either 
female or male sterilisation (including hysterectomy) 
for contraception. We used Stata (version 13.1) for 
complex survey analysis to incorporate weighting, 
clustering and stratification of the Natsal-3 data.13 We 
calculated the percentage of participants (with 95% 
confidence intervals) who had obtained contracep-
tion in the past year from each source and used the 
chi-square statistic to determine whether there were 
statistically significant variation in the reporting of 
these sources by sociodemographic characteristics and 
by lifestyle and sexual health variables. Participants 
were not asked from which sources they obtain specific 
contraceptive methods, and so we were unable to link 
method with source used. However, since use of LARC 
methods was likely to have been of longer duration, we 
included sole use of LARC (intrauterine contraceptives 
and implants) as an independent variable. Injectables 
were not included in the LARC category due to their 
lower continuation rates. Proportional Venn diagrams 
were used to represent the extent of overlap in use 
of different sources among those who had obtained 
contraceptive supplies.
results
Some 4571 women and 3142 men were eligible for 
inclusion in the analysis; 87.0% of women and 73.8% 
of men obtained contraception from at least one source 
in the past year (table 1).
Prevalence of use of different sources of contraception
The source of contraceptive supplies used by the largest 
proportion of women (59.1%) was general prac-
tice. 28.6% obtained supplies from retail outlets, the 
majority being pharmacies. 23% of women obtained 
supplies from community services, predominantly 
FPCs (14.4%) but 8.5% obtained supplies from GUM 
services (table 1). 27.3% of women had used more 
than one source. Women most commonly reported 
use of both general practice and retail sources (11.0%) 
(figure 1).
The source of contraceptive supplies used by the 
largest proportion of men (54.6%) was retail outlets 
(table 1). Among retail suppliers, pharmacies were 
most commonly used by more than one-third of men, 
but petrol stations and supermarkets were used by 
one in four (24.8%) and vending machines by nearly 
one in ten (9.4%). Just over one-fifth (21.3%) of men 
used community clinics, of which GUM services were 
more commonly used than other community services. 
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15.3% of men reported contraception used by them 
being from general practice. 30.6% of men used more 
than one source of contraception, with the greatest 
overlap in use being community clinics and retail 
(11.9%) (figure 1) .
use of contraceptive sources by characteristics of 
participants
General practice
Marked age differences among women were seen in 
the use of general practice for contraceptive supplies 
(table 2). Roughly two-thirds of women in their 20s 
had obtained contraception from this source in the 
past year, compared with half of 16–17-year-olds 
and 35–44-year-olds. Statistically significant differ-
ences were also seen by other demographic variables. 
Women living in rural districts, those in cohabiting or 
‘steady’ relationships as opposed to those who were 
single or married, and childless women compared 
with mothers, all more commonly used general prac-
tice for contraceptive supplies. Half of LARC users 
obtained supplies from general practice. Women with 
minimum educational qualifications, or none, more 
commonly used this source compared with those who 
were more highly qualified. The most marked differ-
ence, however, was seen by ethnic group. Compared 
with women identifying as ‘white’, considerably lower 
proportions of women in black and minority ethnic 
groups obtained contraception from general practice. 
Variation in use of general practice by health behav-
iour was not statistically significant among women.
Among men, the proportions reporting general prac-
tice as a source of contraception in the past year were 
statistically significantly higher among those living 
with a partner, fathers and those reporting only one 
sexual partner during the period (table 3).
Community clinics
Marked age differences were also seen in the use of 
community clinics for contraception. There was a 
strong and consistent age gradient with over half of 
Table 1 Use of sources to obtain contraceptives in the past year among women and men aged 16–44 years who had had vaginal sex 
in the past year
Source of contraceptive supplies Women Men
Denominators (unweighted, weighted)
4571, 3088 3142, 3182
% (95% CI) % (95% CI)
General practice* 59.1 (57.2 to 61.0) 15.3 (13.6 to 17.0)
Community clinic 23.0 (21.6 to 24.5) 21.3 (19.6 to 23.0)
  GUM clinic 8.5 (7.6 to 9.5) 10.8 (9.6 to 12.1)
  Family planning clinic 14.4 (13.2 to 15.7) 6.8 (5.8 to 8.1)
  Youth advisory clinic 1.1 (0.8 to 1.6) 2.1 (1.7 to 2.7)
  School/college/university 2.4 (1.9 to 3.0) 6.4 (5.4 to 7.5)
Retail 28.6 (26.9 to 30.3) 54.6 (52.3 to 56.8)
  Pharmacy/chemist 21.3 (19.8 to 22.9) 35.0 (32.8 to 37.2)
  Internet website 0.7 (0.5 to 1.2) 3.1 (2.4 to 4.0)
  Petrol station/supermarket 10.3 (9.2 to 11.5) 24.8 (23.0 to 26.7)
  Vending machine 0.7 (0.5 to 1.1) 9.4 (8.2 to 10.7)
  Mail order 0.2 (0.1 to 0.4) 0.7 (0.4 to 1.2)
Other 2.9 (2.4 to 3.6) 2.9 (2.3 to 3.6)
  Emergency department at hospital 0.30 (0.2 to 0.5) 0.2 (0.1 to 0.5)
  NHS antenatal clinic 0.90 (0.7 to 1.3) 1.0 (0.7 to 1.5)
  Private doctor 1.3 (0.9 to 1.7) 1.0 (0.7 to 1.4)
  Other 0.5 (0.3 to 0.8) 0.8 (0.5 to 1.3)
Contraception not obtained in the last year 13.0 (11.6 to 14.4) 26.2 (24.2 to 28.3)
 Number of sources used†
  0 13.0 (11.6 to 14.4) 26.2 (24.2 to 28.3)
  1 59.8 (57.9 to 61.6) 43.3 (41.0 to 45.5)
  2 21.0 (19.6 to 22.5) 20.6 (18.9 to 22.4)
  3+ 6.2 (5.5 to 7.1) 10.0 (8.8 to 11.3)
*General practice includes doctor, nurse and general practice surgery.
†Any source rather than source category.
GUM, genitourinary medicine; NHS, National Health Service.
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16–17-year-old women sourcing contraception from 
community clinics compared with fewer than 10% 
of those aged 35–44 years. Other variation by demo-
graphic characteristic tended to reverse that found in 
relation to general practice. Community clinics were 
more commonly used by women living in urban areas, 
women in black and ethnic minority groups, those 
not co-habiting with a partner, and childless women. 
Variation was also seen by demographic characteris-
tics, which were not significantly associated with use 
of general practice. Notable among these was area-re-
lated deprivation; women living in poorer areas 
more commonly sought contraceptive supplies from 
community clinics compared with those living in more 
affluent areas. Statistically significant associations 
between sourcing contraception from community 
clinics and sexual health-related variables were found 
which were also not seen for general practice. Use 
of community clinics was statistically higher among 
women diagnosed with an STI, those with more than 
one partner, and those who had an unplanned preg-
nancy in the past year. 
Among men, the age gradient in use of community 
clinics was even more marked than among women; 
58.9% of 16–19-year-olds had used community clinics 
in the past year, compared with 5.2% of 35–44-year-
olds. Statistically significant differences in use were 
seen by all the sexual health variables.
Retail outlets
Among women, few strong or consistent differences 
in use of retail outlets were seen by demographic 
characteristics, and none by sexual health variables. 
A strong gradient was seen by academic achievement 
with almost one-third of women studying for or having 
attained post-16 qualifications reporting use, compared 
with barely 15% of those with minimum educational 
qualifications or none. Other significant associations 
were observed in relation to parity and ethnicity, with 
women without children (31.9%) and Asian women 
(39.3%) most commonly reporting use of retail outlets.
More variation by demographic characteristic was 
observed among men. Statistically significant differ-
ences were seen by age, educational level, area of resi-
dence, relationship status and parity. Use was highest 
among men aged 20–24 years, those with the highest 
educational qualifications, those living in urban areas, 
those who were neither married nor cohabiting, and 
those without children.
Use of more than one source of contraception
Age differences were seen in the use of more than one 
source of contraceptive supplies. More than one-third 
of women aged under 25 years had used two or more 
sources in the past year. Statistically significant associ-
ations were also seen between multiple use and higher 
educational level, being unmarried, having more than 
one sexual partner in the past year, having been diag-
nosed with an STI, having experienced unplanned 
pregnancy, and being childless.
A broadly similar pattern was observed among men. 
Statistically significant associations were seen between 
use of more than one source and being under 25, being 
unmarried, having two or more partners in the past 
year, an STI diagnosis in the past year and not having 
children.
Figure 1 Extent of overlap in the type(s) of source used to obtain contraceptives in the past year among women and men aged 16–44 years who 
reported vaginal sex in the past year and obtaining contraceptives. These diagrams apply only to those who obtained contraception in the previous year and 
so the percentages differ from those presented in the tables, where the denominator includes those who had not.
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Use of no source of contraception
Some 13% of sexually active women reported having 
used no source of contraceptive supplies in the past 
year, although their partner may have done so. Age was 
associated with non-use, being most common among 
women in the 35–44 years age group. Not having 
used a source of contraception was significantly less 
common among women who were unmarried, child-
less, who had had an unplanned pregnancy during the 
past year, who had more than one sexual partner and 
who had been diagnosed with an STI. The proportion 
was highest among LARC users, rising to 30.8%.
Among men, prevalence of non-use was also higher 
in older age groups. Not having used a source of 
contraceptive supplies was significantly less common 
among unmarried men, those without children, those 
living in urban areas, and those identifying as Black 
Caribbean. It was also lower among men reporting 
more than one sexual partner and among those diag-
nosed with an STI in the past year.
dIscussIon
These data, from a large population-based national 
survey, provide information on patterns of service use 
for contraception among women and men in Britain. 
They show high proportions accessing a source of 
contraceptive supplies in the past year, nearly 90% 
of women and almost three-quarters of men. The 
majority of women, six in ten, use general practice 
and roughly the same proportion of men use retail 
suppliers. Little more than one in five women and 
men access contraception from community clinics, but 
those who do are younger and at greater risk of poor 
sexual health. Similar characteristics are seen for the 
sizeable minority who used more than one source in 
the past year.
A strength of this study is that it provides data from 
a large representative community sample rather than, 
as is more often the case, from attenders at health 
services.17–19 We were able to examine use of contra-
ceptive sources by a wider range of factors than is 
usual, including not only sociodemographic character-
istics but indicators of sexual and reproductive health 
status. Caution is needed in interpreting some find-
ings due to the small numbers in some categories (eg, 
ethnic group). We also need to bear in mind that, in 
identifying the source of contraception used during the 
past year, we cannot be sure that participants were not 
referring to access by their partner and this is perhaps 
more likely to apply in the case of men. Nor were we 
able to establish which contraceptive methods were 
obtained from which sources, and participants may 
have interpreted ‘source’ as their main provider or all 
services involved in obtaining a contraceptive method. 
For example, contraceptive pill/oral contraceptives 
users may get their prescription from a general prac-
titioner (GP) but may have to pick up their supplies 
from a pharmacy. Finally, we were unable to establish 
whether user preference for method determines choice 
of source, or vice versa. While most contraception is 
used for the prevention of pregnancy, other benefits 
such as management of acne or STI protection may 
also affect choice of source to obtain methods. The 
source from which women and men obtain a contra-
ceptive method will depend on a number of variables, 
including which service is able to provide it. Condoms 
are rarely available free of charge from general prac-
tice in Britain; hormonal methods (emergency contra-
ception excepted) are not available from retail outlets; 
and methods such as withdrawal and periodic absti-
nence require no contact with a provider.
Although direct comparisons with data from 
Natsal-2, conducted between 1999 and 2001, are 
not possible because of slight differences in ques-
tion wording (Natsal-2 asked about use of sources 
of contraceptive advice or supplies while Natsal-3 
asked only about supplies), we can nevertheless 
identify some shifts in patterns of use between the 
two surveys.10 A marked increase can be seen in 
use of any source of contraceptive supplies by the 
whole population aged 16–44 years, but especially 
among younger men. Two-thirds of men aged under 
20 had accessed no source of contraception (for 
either advice or supplies) in 2000 but a decade later 
nine in ten reported accessing a service for supplies. 
Prevalence of sources of contraception is still ranked 
in the same order as was seen in Natsal-2. General 
practice remains the source used by the majority of 
women, the proportion of women using this source 
is virtually unchanged between the surveys (59.2% 
in Natsal-2). By contrast, although still accessed 
by smaller proportions, use of community clinics 
by both women and men increased between 2000 
and 2010, as did use of retail outlets. In Natsal-2, 
15.0% of women and 7.7% of men reported use 
of community clinics in the last year and 22.5% 
and 42.7%, respectively, reported use of retail. 
Commensurate with these changes, reported use of 
more than one source of contraception was higher 
in Natsal-3 than in Natsal-2, especially among men.
If these data represent true trends and not simply 
changes to question wording, they may reflect recent 
changes in public health policy and practice. The 
increase in the use of any source of contraception 
by men may follow from the now broader range of 
services available, including school- and college-based 
services. It may also be associated with a shift in focus 
from traditionally organised, women-centred family 
planning services towards integrated sexual and repro-
ductive health services likely to have broader appeal 
in which staff may be better able to discuss contra-
ception with young men attending for STI-related 
reasons.7 8 The increase in use of community clinics, 
which is consistent with increases in attendance 
observed using routinely collected clinic data,20 is 
likely to be welcomed by commissioners and providers 
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in Britain as validating the considerable efforts made 
at the start of the 21st century to reach their target 
clientele. Their higher prevalence of use among the 
young, those living in more deprived areas, and those 
at greater sexual health risk is consistent with the 
growth in the number of dedicated young people’s 
services, increased accessibility, extended opening 
hours and capacity to provide drop-in services. The 
trend towards greater use of retail services by women 
may reflect greater availability of over-the-counter 
emergency contraception. The high proportion of 
LARC users reporting use of no service, almost a third, 
is likely to be attributable to the growing number of 
women using LARC methods which require few visits 
to services.
This said, general practice is still the mainstay of 
contraceptive provision in Britain, at least among 
women. Healthcare professionals in this setting 
provide services to more women who are single, 
multi-partnered and living in more deprived areas with 
contraception than do those in community clinics. 
General practice supplies twice as many women with 
LARC methods than community clinics, which may 
reflect financial incentives to increase LARC uptake 
introduced in general practice.21 It follows that staff in 
general practice are still vitally important as a source 
of contraceptive supplies and need to maintain their 
skills and willingness to provide all methods. This is 
especially so in rural areas where community clinics 
are less commonly situated, a fact consistent with 
evidence in our data of lower rates of their use outside 
cities and towns. However, while there has been some 
evidence that LARC provision has been increasing in 
general practice, these methods may not be available 
in many practices requiring referral to more specialist 
services.17 22
We cannot tell whether the increase in use of multiple 
sources in general, and in particular among young 
people, is attributable to users ‘shopping around’ to 
find out which service best suits their needs, whether 
the mix of contraceptive methods they use requires 
use of different services or whether young people are 
more likely to be referred between different services 
compared with those in older age groups. These issues 
may require further investigation. Data from Natsal-3 
on actual and preferred use of sources of contraceptive 
supplies showed that one-third of those aged under 
25 years reported not having accessed their preferred 
source and this discordance was associated with use of 
less effective contraception and markers of poor sexual 
and reproductive health.23
These data on variation in the use of different 
sources by users’ characteristics will be of interest to 
those planning, purchasing and providing services. 
They may also provide evidence supporting the 
retention and expansion of community-based 
services. In England, local authorities are respon-
sible for ensuring the availability of “confidential, 
open access services for STIs and contraception as 
well as reasonable access to all methods of contra-
ception”.24 This includes costs of the contraceptive 
methods or prescriptions and specialist sexual health 
services. Additional services provided in general 
practice, such as contraceptive advice and medical 
examinations of those seeking advice (excluding the 
fitting of any contraceptive devices), are commis-
sioned by NHS England under the GP contract. 
Concerns have been raised that the move to the 
commissioning of enhanced contraceptive services 
to local authorities will lead to greater centralisa-
tion of services and fewer services providing more 
specialist care and facilities.25 Although access to 
contraception has widened over the last decade, 
there remains yet more potential for expanding 
services in community pharmacies and via the 
internet, such as by the provision of oral contracep-
tives.26–28 The increase in the choice of sources for 
contraceptive supplies and greater choice of contra-
ceptive methods available from these sources have 
coincided with a decline in teenage pregnancy.29 30 
A strong case can be made for continuing to provide 
high-quality services in different settings and with 
different styles of service delivery. 
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